Consonance Capital Management LP Puma Biotechnology, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$20.07 - $46.7 $46.2 Million - $108 Million
-2,303,455 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$41.2 - $59.85 $8.83 Million - $12.8 Million
214,338 Added 10.26%
2,303,455 $106 Million
Q2 2018

Aug 14, 2018
BUY
$48.3 - $68.25 $101 Million - $143 Million
2,089,117 New
2,089,117 $124 Million

Others Institutions Holding PBYI

# of Institutions
98
Shares Held
29.3M
Call Options Held
73.5K
Put Options Held
18.5K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $135M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email